Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein Db/IIIa blocker Integrelin in elective coronary intervention - Tcheng, J E; Harrington, R A; Kottke-Marchant, K; Kleiman, N S; Ellis, S G; Kereiakes, D J; Mick, M J; Navetta, F I; Smith, J E; Worley, S J (IMPACT Investigators, 1995)